(USFD) US Foods Holding - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9120081099
Stock: Fresh, Frozen, Dry, Non-Food, Foodservice
Total Rating 60
Risk 76
Buy Signal 2.18
| Risk 5d forecast | |
|---|---|
| Volatility | 46.5% |
| Relative Tail Risk | -8.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 35.38 |
| Character TTM | |
|---|---|
| Beta | 0.701 |
| Beta Downside | 0.662 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.01% |
| CAGR/Max DD | 2.05 |
EPS (Earnings per Share)
Revenue
Description: USFD US Foods Holding February 13, 2026
US Foods Holding Corp. (NYSE:USFD) markets, sells, and distributes a broad portfolio of fresh, frozen, dry, and non-food products to a diverse U.S. food-service clientele, ranging from independent restaurants and national chains to hospitals, hotels, and government institutions.
Key recent metrics (FY 2025): net sales of $34.6 billion, representing a 2 % year-over-year increase; adjusted EBITDA margin of 5.6 %; and operating cash flow of $2.1 billion, indicating modest earnings growth amid a tightening labor market and elevated commodity prices.
Sector drivers that directly affect US Foods include: (1) restaurant-industry traffic, which grew ~3 % YoY in 2025 after a pandemic-era rebound; (2) institutional spending trends, with hospital food-service budgets expanding 1.8 % YoY; and (3) input-cost inflation, where meat and dairy prices have averaged a 4.2 % year-over-year rise, pressuring margins across food distributors.
For a deeper, data-driven look at USFD’s valuation and risk profile, the ValueRay platform provides a concise snapshot worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 558.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.64 > 1.0 |
| NWC/Revenue: 1.43% < 20% (prev 1.73%; Δ -0.31% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.36b > Net Income 558.0m |
| Net Debt (4.90b) to EBITDA (1.50b): 3.26 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (228.4m) vs 12m ago -6.39% < -2% |
| Gross Margin: 17.41% > 18% (prev 0.17%; Δ 1724 % > 0.5%) |
| Asset Turnover: 284.3% > 50% (prev 277.0%; Δ 7.30% > 0%) |
| Interest Coverage Ratio: 3.41 > 6 (EBITDA TTM 1.50b / Interest Expense TTM 307.0m) |
Altman Z'' 1.63
| A: 0.04 (Total Current Assets 4.37b - Total Current Liabilities 3.81b) / Total Assets 14.04b |
| B: 0.18 (Retained Earnings 2.50b / Total Assets 14.04b) |
| C: 0.08 (EBIT TTM 1.05b / Avg Total Assets 13.76b) |
| D: 0.27 (Book Value of Equity 2.54b / Total Liabilities 9.57b) |
| Altman-Z'' Score: 1.63 = BB |
Beneish M -3.06
| DSRI: 1.02 (Receivables 2.43b/2.28b, Revenue 39.12b/37.32b) |
| GMI: 0.99 (GM 17.41% / 17.30%) |
| AQI: 0.97 (AQ_t 0.50 / AQ_t-1 0.52) |
| SGI: 1.05 (Revenue 39.12b / 37.32b) |
| TATA: -0.06 (NI 558.0m - CFO 1.36b) / TA 14.04b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of USFD shares?
As of February 13, 2026, the stock is trading at USD 101.98 with a total of 8,519,494 shares traded.
Over the past week, the price has changed by +16.03%, over one month by +31.91%, over three months by +39.89% and over the past year by +45.87%.
Over the past week, the price has changed by +16.03%, over one month by +31.91%, over three months by +39.89% and over the past year by +45.87%.
Is USFD a buy, sell or hold?
US Foods Holding has received a consensus analysts rating of 4.47.
Therefore, it is recommended to buy USFD.
- StrongBuy: 10
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the USFD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 91.6 | -10.1% |
| Analysts Target Price | 91.6 | -10.1% |
| ValueRay Target Price | 134.5 | 31.9% |
USFD Fundamental Data Overview February 11, 2026
P/E Trailing = 37.55
P/E Forward = 19.0476
P/S = 0.5188
P/B = 4.4937
P/EG = 0.2439
Revenue TTM = 39.12b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 1.50b USD
Long Term Debt = 4.83b USD (from longTermDebt, last quarter)
Short Term Debt = 120.0m USD (from shortTermDebt, last quarter)
Debt = 4.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.90b USD (from netDebt column, last quarter)
Enterprise Value = 25.19b USD (20.29b + Debt 4.95b - CCE 56.0m)
Interest Coverage Ratio = 3.41 (Ebit TTM 1.05b / Interest Expense TTM 307.0m)
EV/FCF = 25.76x (Enterprise Value 25.19b / FCF TTM 978.0m)
FCF Yield = 3.88% (FCF TTM 978.0m / Enterprise Value 25.19b)
FCF Margin = 2.50% (FCF TTM 978.0m / Revenue TTM 39.12b)
Net Margin = 1.43% (Net Income TTM 558.0m / Revenue TTM 39.12b)
Gross Margin = 17.41% ((Revenue TTM 39.12b - Cost of Revenue TTM 32.30b) / Revenue TTM)
Gross Margin QoQ = 17.20% (prev 17.63%)
Tobins Q-Ratio = 1.79 (Enterprise Value 25.19b / Total Assets 14.04b)
Interest Expense / Debt = 1.53% (Interest Expense 76.0m / Debt 4.95b)
Taxrate = 25.73% (53.0m / 206.0m)
NOPAT = 778.4m (EBIT 1.05b * (1 - 25.73%))
Current Ratio = 1.15 (Total Current Assets 4.37b / Total Current Liabilities 3.81b)
Debt / Equity = 1.11 (Debt 4.95b / totalStockholderEquity, last quarter 4.47b)
Debt / EBITDA = 3.26 (Net Debt 4.90b / EBITDA 1.50b)
Debt / FCF = 5.01 (Net Debt 4.90b / FCF TTM 978.0m)
Total Stockholder Equity = 4.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.06% (Net Income 558.0m / Total Assets 14.04b)
RoE = 12.24% (Net Income TTM 558.0m / Total Stockholder Equity 4.56b)
RoCE = 11.16% (EBIT 1.05b / Capital Employed (Equity 4.56b + L.T.Debt 4.83b))
RoIC = 8.08% (NOPAT 778.4m / Invested Capital 9.63b)
WACC = 7.06% (E(20.29b)/V(25.24b) * Re(8.50%) + D(4.95b)/V(25.24b) * Rd(1.53%) * (1-Tc(0.26)))
Discount Rate = 8.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.07%
[DCF Debug] Terminal Value 84.40% ; FCFF base≈874.0m ; Y1≈1.08b ; Y5≈1.84b
Fair Price DCF = 149.8 (EV 38.30b - Net Debt 4.90b = Equity 33.41b / Shares 222.9m; r=7.06% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 76.62 | EPS CAGR: 31.79% | SUE: 0.46 | # QB: 0
Revenue Correlation: 89.82 | Revenue CAGR: 7.99% | SUE: 0.31 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.84 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=14
EPS next Year (2026-12-31): EPS=4.70 | Chg30d=+0.025 | Revisions Net=-1 | Growth EPS=+19.4% | Growth Revenue=+6.2%
P/E Forward = 19.0476
P/S = 0.5188
P/B = 4.4937
P/EG = 0.2439
Revenue TTM = 39.12b USD
EBIT TTM = 1.05b USD
EBITDA TTM = 1.50b USD
Long Term Debt = 4.83b USD (from longTermDebt, last quarter)
Short Term Debt = 120.0m USD (from shortTermDebt, last quarter)
Debt = 4.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.90b USD (from netDebt column, last quarter)
Enterprise Value = 25.19b USD (20.29b + Debt 4.95b - CCE 56.0m)
Interest Coverage Ratio = 3.41 (Ebit TTM 1.05b / Interest Expense TTM 307.0m)
EV/FCF = 25.76x (Enterprise Value 25.19b / FCF TTM 978.0m)
FCF Yield = 3.88% (FCF TTM 978.0m / Enterprise Value 25.19b)
FCF Margin = 2.50% (FCF TTM 978.0m / Revenue TTM 39.12b)
Net Margin = 1.43% (Net Income TTM 558.0m / Revenue TTM 39.12b)
Gross Margin = 17.41% ((Revenue TTM 39.12b - Cost of Revenue TTM 32.30b) / Revenue TTM)
Gross Margin QoQ = 17.20% (prev 17.63%)
Tobins Q-Ratio = 1.79 (Enterprise Value 25.19b / Total Assets 14.04b)
Interest Expense / Debt = 1.53% (Interest Expense 76.0m / Debt 4.95b)
Taxrate = 25.73% (53.0m / 206.0m)
NOPAT = 778.4m (EBIT 1.05b * (1 - 25.73%))
Current Ratio = 1.15 (Total Current Assets 4.37b / Total Current Liabilities 3.81b)
Debt / Equity = 1.11 (Debt 4.95b / totalStockholderEquity, last quarter 4.47b)
Debt / EBITDA = 3.26 (Net Debt 4.90b / EBITDA 1.50b)
Debt / FCF = 5.01 (Net Debt 4.90b / FCF TTM 978.0m)
Total Stockholder Equity = 4.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.06% (Net Income 558.0m / Total Assets 14.04b)
RoE = 12.24% (Net Income TTM 558.0m / Total Stockholder Equity 4.56b)
RoCE = 11.16% (EBIT 1.05b / Capital Employed (Equity 4.56b + L.T.Debt 4.83b))
RoIC = 8.08% (NOPAT 778.4m / Invested Capital 9.63b)
WACC = 7.06% (E(20.29b)/V(25.24b) * Re(8.50%) + D(4.95b)/V(25.24b) * Rd(1.53%) * (1-Tc(0.26)))
Discount Rate = 8.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.07%
[DCF Debug] Terminal Value 84.40% ; FCFF base≈874.0m ; Y1≈1.08b ; Y5≈1.84b
Fair Price DCF = 149.8 (EV 38.30b - Net Debt 4.90b = Equity 33.41b / Shares 222.9m; r=7.06% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 76.62 | EPS CAGR: 31.79% | SUE: 0.46 | # QB: 0
Revenue Correlation: 89.82 | Revenue CAGR: 7.99% | SUE: 0.31 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.84 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=14
EPS next Year (2026-12-31): EPS=4.70 | Chg30d=+0.025 | Revisions Net=-1 | Growth EPS=+19.4% | Growth Revenue=+6.2%